Literature DB >> 24266685

Anti-Inflammatory, gastrointestinal and hepatoprotective effects of Ocimum sanctum Linn: an ancient remedy with new application.

Amir A 'lam Kamyab, Ahad Eshraghian1.   

Abstract

Herbal medicine has a long background equal to history of humankind. Several plants have been used as remedies in ancient Persian, Egyptian, Chinese and Indian civilizations. The plant Ocimum sanctum Linn. (Tulsi) is one of these medicinal plants with a wide variety of applications in traditional medicine. In modern era, it has been shown to be effective against diabetes mellitus, hypertension, cancers, bronchitis, and found to have anti-microbial properties. Several experimental studies have confirmed its anti-inflammatory properties and its role in modulation of both cellular and humeral immunity. Recently its efficacy against inflammatory response, hepatic injury and gastric ulcer has been elucidated in animal studies. In liver, essential oils and extracts of Ocimum sanctum could prevent oxidative stress by increasing glutathione peroxidae and catalase and were also effective in prevention of hepatic steatosis. In gastric epithelial tissue different derivatives of Ocimum sanctum had anti-ulcer and anti-secretory characteristics and could heal gastric ulceration. These beneficial properties of this medicinal plant can mainly originate from its major biochemically active constituents like eugenol, carvacrol, ursolic acid, β-caryophyllene and rosmarinic acid. Here in, we reviewed current literature about anti-inflammatory, gastric and hepatoprotective properties of Ocimum sanctum.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24266685     DOI: 10.2174/1871528112666131125110017

Source DB:  PubMed          Journal:  Inflamm Allergy Drug Targets        ISSN: 1871-5281


  7 in total

1.  β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19.

Authors:  Niraj Kumar Jha; Charu Sharma; Hebaallah Mamdouh Hashiesh; Seenipandi Arunachalam; Mf Nagoor Meeran; Hayate Javed; Chandragouda R Patil; Sameer N Goyal; Shreesh Ojha
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

2.  Chinese herbal decoction based on syndrome differentiation as maintenance therapy in patients with extensive-stage small-cell lung cancer: an exploratory and small prospective cohort study.

Authors:  Rui Liu; Shu Lin He; Yuan Chen Zhao; Hong Gang Zheng; Cong Huang Li; Yan Ju Bao; Ying Gang Qin; Wei Hou; Bao Jin Hua
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-01       Impact factor: 2.629

Review 3.  The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature.

Authors:  Negar Jamshidi; Marc M Cohen
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-16       Impact factor: 2.629

Review 4.  Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India.

Authors:  Sreyashi Majumdar; Rohit Verma; Avishek Saha; Parthasarathi Bhattacharyya; Pradipta Maji; Milan Surjit; Manikuntala Kundu; Joyoti Basu; Sudipto Saha
Journal:  Front Genet       Date:  2021-02-16       Impact factor: 4.599

5.  Comparative clinical data for gingivitis treatment using gels from Ocimum sanctum (Tulsi) and chlorhexidine (CHX).

Authors:  B A Deepika; Jaiganesh Ramamurthy; Nadathur Duraisamy Jayakumar; S Rajesh Kumar
Journal:  Bioinformation       Date:  2021-12-31

6.  A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract (HolixerTM) on stress, mood, and sleep in adults experiencing stress.

Authors:  Adrian L Lopresti; Stephen J Smith; Alexandra P Metse; Peter D Drummond
Journal:  Front Nutr       Date:  2022-09-02

7.  Antifungal activity of solvent extracts of Piper betle and Ocimum sanctum Linn on Candida albicans: An in vitro comparative study.

Authors:  Basireddy Sivareddy; Bernard Ajay Reginald; D Sireesha; Meda Samatha; K Himakar Reddy; G Subrahamanyam
Journal:  J Oral Maxillofac Pathol       Date:  2019 Sep-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.